- Home
- PBYI vs INBK Comparison
PBYI vs INBK Comparison
Compare PBYI & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- INBK
- Stock Information
- Founded
- PBYI 2010
- INBK 1999
- Country
- PBYI United States
- INBK United States
- Employees
- PBYI N/A
- INBK N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- INBK Major Banks
- Sector
- PBYI Health Care
- INBK Finance
- Exchange
- PBYI Nasdaq
- INBK Nasdaq
- Market Cap
- PBYI 164.3M
- INBK 196.2M
- IPO Year
- PBYI N/A
- INBK N/A
- Fundamental
- Price
- PBYI $3.54
- INBK $28.00
- Analyst Decision
- PBYI Strong Buy
- INBK Buy
- Analyst Count
- PBYI 1
- INBK 4
- Target Price
- PBYI $7.00
- INBK $34.50
- AVG Volume (30 Days)
- PBYI 306.9K
- INBK 41.7K
- Earning Date
- PBYI 07-31-2025
- INBK 07-23-2025
- Dividend Yield
- PBYI N/A
- INBK 0.86%
- EPS Growth
- PBYI 143.51
- INBK 27.37
- EPS
- PBYI 0.77
- INBK 2.40
- Revenue
- PBYI $232,709,000.00
- INBK $114,609,000.00
- Revenue This Year
- PBYI N/A
- INBK $5.36
- Revenue Next Year
- PBYI N/A
- INBK $17.09
- P/E Ratio
- PBYI $4.64
- INBK $11.67
- Revenue Growth
- PBYI 2.68
- INBK 20.13
- 52 Week Low
- PBYI $2.23
- INBK $19.54
- 52 Week High
- PBYI $4.13
- INBK $43.27
- Technical
- Relative Strength Index (RSI)
- PBYI 58.61
- INBK 70.66
- Support Level
- PBYI $3.26
- INBK $26.63
- Resistance Level
- PBYI $3.65
- INBK $28.12
- Average True Range (ATR)
- PBYI 0.14
- INBK 0.88
- MACD
- PBYI 0.01
- INBK 0.39
- Stochastic Oscillator
- PBYI 84.78
- INBK 100.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.